Rakuten Aspyrian
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
2
Funding Rounds
$434.0m
Money raised
Overview
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
- Website:
- Headquarters: San Diego
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Rakuten Aspyrian has raised a total of $284m in funding over 2 rounds.
Key Insights:
- Rakuten Aspyrian Series C round, December 2018: $284m
- Rakuten Aspyrian funding round, August 2018: $150m
Rakuten Aspyrian Series C round, December 2018
$284m
Rakuten Aspyrian funding round, August 2018
$150m
Industries
Rakuten Aspyrian is active in the following industries:
- Biopharmaceutical
- Technology
- Biology
- Biotechnology
- Internal medicine
- Healthcare
- Medicine
- Cancer
- Oncology
- Diagnosis